South East Wales Collaborative Cancer Leadership Group

South East Wales Collaborative Cancer Leadership group

Unit 2 Charnwood Court
Heol Billingsley, Parc Nantgarw,
Cardiff
CF15 7QZ

 

ABOUT

Cancer Services in South East Wales are working to attract hundreds of millions of pounds of public and private sector investment to deliver significant improvements in patient outcomes and experience. This investment will provide ‘state of the art’ infrastructure, technology and equipment. Collaborative Research, Development, Innovation and Education are key themes with partnerships and collaboration across sectors, organisations and disciplines (across South East Wales and beyond) and are central to delivering clinical, research and financial objectives.

To provide system wide leadership of this significant investment and change process, the South East Wales Collaborative Cancer Leadership Group (CCLG) has been established.  Chaired by Suzanne Rankin, CEO, Cardiff & Vale UHB, CCLG membership includes Executive Directors and the Clinical Cancer Leads from the statutory bodies responsible for delivery of cancer services: Cwm Taf Morgannwg UHB, Aneurin Bevan UHB, Cardiff & Vale UHB, Powys THB and Velindre University NHS Trust. These organisations are working in partnership with key national actors including Public Health Wales, Health Education & Improvement Wales, Digital Health and Care Wales, the Wales Cancer Network, the Life Science Hub and Cancer Research Wales. The Collaboration Partners are also active with third sector partners, industry and the Regions City Deal. A Transformation Programme Office hosted by Velindre University NHS Trust supports the Cancer Collaborative.

To achieve a transformation in outcomes and experience for patients with cancer in South East Wales, it is essential to develop a long-term approach to whole system functioning based upon collaboration and partnership with a programme of work that will span the breadth of the cancer pathway from prevention to treatment and living with the impact of cancer. An importance is placed on Research, Development and Innovation as key enablers of high system performance. Our Strategy sets down our Research Themes as:

  • Putting patients first and at the centre of everything we do: patients will help set the research agenda and we aim to increase opportunities for patients and their families so that within 10 years most of our patients are offered research and innovation opportunities.
  • Advancing new treatments, interventions and care: We will lead and take part in well-designed Clinical Trials and other research studies, providing the evidence base required to bring new, improved treatments and interventions into the clinic to enhance patient care. New infrastructure for research delivery will be developed, including a Tripartite Cardiff Cancer Research Hub for Early Phase and Translational research delivery on the University Hospital of Wales (UHW) site and a firm footprint for research at the new Velindre Cancer Centre, particularly to enable cutting-edge radiotherapy research.
  • Driving translational research through connecting the laboratory and clinic: We will work closely with our academic (university) partners to enable translational (‘bench to bedside’) research, bringing new discoveries (novel drugs, imaging techniques and/or technological advances) through from the laboratory to the clinic to benefit patients. We will also enable reverse translation (‘bedside to bench’) research where patient samples/scans and/or data are taken back to the laboratory to generate new knowledge.
  • Embedding research and innovation within the organisational culture: We will establish an organisational culture that values research and build capacity and capability.

 

The Collaborative Research, Development and Innovation Portfolio include:

  • Strategic Radiotherapy Research Partnership
  • Dedicated Radiotherapy Research Bunker
  • Research Hub at UHW,
  • Collaborative Centre for Learning and Innovation at Velindre Cancer Centre
  • Prehabilitation to Rehabilitation Pathway
  • Sustainable Healthcare
  • City Deal Opportunities

The Cancer Collaborative is able to offer research opportunities across a whole region, spanning the whole pathway of cancer care, alongside a multi-disciplinary approach and a broad eco system of partners with which to build value.

The Collaborative are seeking to:

  • Partner and collaborate with industry, investors and research organisations across the healthcare/technology/science industry.
  • Build long term relations that build mutually beneficial value for partners.
  • To share and benefit from good practice across the UK and internationally.
  • Access other networks to seek wider collaborations and to assist others.

 

The Cancer Collaborative offers physical and virtual collaboration opportunities across a range of specialist academic, tertiary, secondary, community and primary care services and infrastructure across the whole cancer pathway with strong links to academia. The potential for value creation is significant. Potential enquiries can be sent to   Velindre.innovation@wales.nhs.uk

NEWS

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Interested in joining UKSPA?

Gain exclusive access to members only resources, research papers, statistics and data – as well as discounted or even free entry to the conferences and events we hold through the year.